Predictions
Aravive, Inc.
Start price
Target price
Perf. (%)
€3.92
17.05.21
17.05.21
€5.00
17.05.22
17.05.22
6.12%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.65
17.05.21
17.05.21
€8.00
17.05.22
17.05.22
1.50%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Kezar Life Sciences
Start price
Target price
Perf. (%)
€4.44
17.05.21
17.05.21
€6.00
17.05.22
17.05.22
2.70%
31.05.21
31.05.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€6.73
17.05.21
17.05.21
€8.00
17.05.22
17.05.22
7.58%
31.05.21
31.05.21
Could be very worthwhile Investment >20% year
Calithera Biosciences Inc.
Start price
Target price
Perf. (%)
€35.80
17.05.21
17.05.21
-
17.05.22
17.05.22
-88.46%
18.05.22
18.05.22
Could be worthwhile Investment >10% per year
MPH Health Care AG
Start price
Target price
Perf. (%)
€26.00
16.05.21
16.05.21
€40.00
16.05.22
16.05.22
-5.77%
29.01.22
29.01.22
Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€74.55
07.05.21
07.05.21
€60.00
07.05.22
07.05.22
-37.42%
08.05.22
08.05.22
Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€15.25
06.05.21
06.05.21
€18.40
06.05.22
06.05.22
23.09%
11.06.21
11.06.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€40.55
04.05.21
04.05.21
€55.00
04.05.22
04.05.22
-11.84%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€27.36
04.05.21
04.05.21
€12.00
04.05.22
04.05.22
-39.47%
05.05.21
05.05.21
Could be worthwhile Investment >10% per year
Good culture
Little innovation
Immutep LTD ADR
Start price
Target price
Perf. (%)
€2.70
04.05.21
04.05.21
-
04.05.22
04.05.22
-8.89%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Precipio Inc
Start price
Target price
Perf. (%)
€5.51
04.05.21
04.05.21
-
04.05.22
04.05.22
-82.03%
05.05.22
05.05.22
Could be very worthwhile Investment >20% year
Ensign Group Inc.
Start price
Target price
Perf. (%)
€71.50
03.05.21
03.05.21
€78.00
03.05.22
03.05.22
2.80%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Precipio Inc
Start price
Target price
Perf. (%)
€2.03
03.05.21
03.05.21
€3.00
03.05.22
03.05.22
194.54%
04.05.21
04.05.21
Could be very worthwhile Investment >20% year
Good culture
Capable Management
Few uniques
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€81.20
03.05.21
03.05.21
€75.00
03.05.22
03.05.22
-41.82%
04.05.22
04.05.22
Could be worthwhile Investment >10% per year
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.50
03.05.21
03.05.21
€8.00
03.05.22
03.05.22
2.31%
17.05.21
17.05.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.72
03.05.21
03.05.21
€5.00
03.05.22
03.05.22
-5.88%
17.05.21
17.05.21
Could be worthwhile Investment >10% per year
Kezar Life Sciences
Start price
Target price
Perf. (%)
€4.72
03.05.21
03.05.21
€6.00
03.05.22
03.05.22
-5.93%
17.05.21
17.05.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€7.90
03.05.21
03.05.21
€10.00
03.05.22
03.05.22
-15.32%
17.05.21
17.05.21
Could be very worthwhile Investment >20% year
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€23.00
02.05.21
02.05.21
-
02.05.22
02.05.22
-82.60%
03.05.22
03.05.22
Could be worthwhile Investment >10% per year
Haemato AG
Start price
Target price
Perf. (%)
€28.90
02.05.21
02.05.21
€35.00
02.05.22
02.05.22
-4.50%
15.05.21
15.05.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.70
02.05.21
02.05.21
-
02.05.22
02.05.22
1.08%
16.05.21
16.05.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Ascendis Ph.sp.adr 1 Dk 1
Start price
Target price
Perf. (%)
€120.00
02.05.21
02.05.21
€125.00
02.05.22
02.05.22
-28.33%
03.05.22
03.05.22
Could be worthwhile Investment >10% per year